Close

J&J (JNJ) Announces Submission of Application to the U.S. FDA for EUA of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. ENPH
3. TXN
4. META
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. KMB


Go back to J&J (JNJ) Announces Submission of Application to the U.S. FDA for EUA of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate

Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate

February 4, 2021 5:35 PM EST

NEW BRUNSWICK, N.J., Feb. 4, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its investigational single-dose Janssen COVID-19 vaccine candidate. The Company's EUA submission is based on... More